These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 15835271)
1. The syntrophin-dystrobrevin subcomplex in human neuromuscular disorders. Compton AG; Cooper ST; Hill PM; Yang N; Froehner SC; North KN J Neuropathol Exp Neurol; 2005 Apr; 64(4):350-61. PubMed ID: 15835271 [TBL] [Abstract][Full Text] [Related]
2. Differential association of syntrophin pairs with the dystrophin complex. Peters MF; Adams ME; Froehner SC J Cell Biol; 1997 Jul; 138(1):81-93. PubMed ID: 9214383 [TBL] [Abstract][Full Text] [Related]
3. Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy. Jones KJ; Compton AG; Yang N; Mills MA; Peters MF; Mowat D; Kunkel LM; Froehner SC; North KN Neuromuscul Disord; 2003 Aug; 13(6):456-67. PubMed ID: 12899872 [TBL] [Abstract][Full Text] [Related]
4. Profound human/mouse differences in alpha-dystrobrevin isoforms: a novel syntrophin-binding site and promoter missing in mouse and rat. Böhm SV; Constantinou P; Tan S; Jin H; Roberts RG BMC Biol; 2009 Dec; 7():85. PubMed ID: 19961569 [TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex. Newey SE; Benson MA; Ponting CP; Davies KE; Blake DJ Curr Biol; 2000 Oct; 10(20):1295-8. PubMed ID: 11069112 [TBL] [Abstract][Full Text] [Related]
6. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1. Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519 [TBL] [Abstract][Full Text] [Related]
7. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies. Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784 [TBL] [Abstract][Full Text] [Related]
8. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related]
9. Syntrophin isoforms at the neuromuscular junction: developmental time course and differential localization. Kramarcy NR; Sealock R Mol Cell Neurosci; 2000 Mar; 15(3):262-74. PubMed ID: 10736203 [TBL] [Abstract][Full Text] [Related]
10. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin. Adams ME; Tesch Y; Percival JM; Albrecht DE; Conhaim JI; Anderson K; Froehner SC J Cell Sci; 2008 Jan; 121(Pt 1):48-54. PubMed ID: 18057022 [TBL] [Abstract][Full Text] [Related]
11. Spatial distribution and molecular dynamics of dystrophin glycoprotein components at the neuromuscular junction Aittaleb M; Martinez-Pena Y Valenzuela I; Akaaboune M J Cell Sci; 2017 May; 130(10):1752-1759. PubMed ID: 28364093 [TBL] [Abstract][Full Text] [Related]
17. Components of the basal lamina and dystrophin-dystroglycan complex in the neurointermediate lobe of rat pituitary gland: different localizations of beta-dystroglycan, dystrobrevins, alpha1-syntrophin, and aquaporin-4. Pócsai K; Bagyura Z; Kálmán M J Histochem Cytochem; 2010 May; 58(5):463-79. PubMed ID: 20124096 [TBL] [Abstract][Full Text] [Related]
18. Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. Crawford GE; Faulkner JA; Crosbie RH; Campbell KP; Froehner SC; Chamberlain JS J Cell Biol; 2000 Sep; 150(6):1399-410. PubMed ID: 10995444 [TBL] [Abstract][Full Text] [Related]
19. Dystrobrevin dynamics in muscle-cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy? Blake DJ Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S110-7. PubMed ID: 12206805 [TBL] [Abstract][Full Text] [Related]